Malaysian Genomics Resource Centre

MGRC

MYQ0155OO000

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA Other stock markets 18:00:00 2024-07-16 EDT			5-day change	1st Jan Change
0.405 ^MYR	0.00%		+1.25%	-8.99%

07-08	Malaysian Genomics Picks Up MYR2.5 Million Stake in Genotec	MT
06-10	Malaysian Genomics Resource Forge Strategic Alliance with South Korean Healthcare Solutions Provider	MT

Malaysian Genomics Resource Centre Berhad Appoints Mr. Ku Chong Hong as Independent and Non Executive Chairman of Audit Committee

January 19, 2022 at 10:05 am

Malaysian Genomics Resource Centre Berhad announced the appointment of Mr. Ku Chong Hong as Independent and Non Executive Chairman of Audit Committee. Date of change is 19 January, 2022.

Latest news about Malaysian Genomics Resource Centre

Malaysian Genomics Picks Up MYR2.5 Million Stake in Genotec	07-08	MT
Malaysian Genomics Resource Forge Strategic Alliance with South Korean Healthcare Solutions Provider	06-09	MT
Malaysian Genomics Resource Trims Attributable Loss in Q1 as Revenue Soars	05-23	MT
Malaysian Genomics Resource Centre Berhad Reports Earnings Results for the First Quarter Ended March 31, 2024	05-23	CI
Malaysian Genomics Resource, Twistcode Technologies In Bioinformatics Tie-Up Talks	05-07	MT
Malaysian Genomics Resource Centre Berhad Announces Aswath A/L Ramakrishnan, Independent and Non Executive Director Was Not Reelected by Shareholders At the Annual General Meeting	04-29	CI
Malaysian Genomics Resource, DE Cell Forge Strategic Alliance	04-18	MT
Malaysian Genomics Resource, Universiti Sains Malaysia Tie Up for Genetics Study	03-14	MT
Malaysian Genomics Resource Centre Berhad Announces Collaboration Agreement with Universiti Sains Malaysia	03-13	CI
Malaysian Genomics Resource Centre Berhad Announces Redesignation of Encik Muhammad Badri Bin Hussin to Chief Operating Officer from Director	03-07	CI
Malaysian Genomics Resource Centre Berhad Announces Appointment of Mohammad Hasni Bin Ibrahim as Independent and Non Executive Member of Audit Committee	03-04	CI
Malaysian Genomics Resource Centre Berhad Announces Resignation of Muhammad Badri Bin Hussin as Independent and Non Executive Member of Audit Committee	03-04	CI
Malaysian Genomics Resource Centre Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-28	CI
Malaysian Genomics Resource Centre Berhad Reports Earnings Results for the Eighteen Months Ended December 31, 2023	02-28	CI
Malaysian Genomics Resource Centre Berhad Appoints Mohammad Hasni Bin Ibrahim as Independent and Non Executive Director	02-02	CI
Malaysian Genomics Resource Centre Berhad Appoints Datuk Wira Muhammad Faizal Bin Zainol as Independent and Non Executive Director	02-02	CI
Malaysian Genomics Resource Centre Berhad Announces Re-Designation of Aswath A/L Ramakrishnan as A Non-Audit and Risk Management Committee Member	12-15	CI
Malaysian Genomics Resource Centre Berhad Reports Earnings Results for the Third Quarter Ended September 30, 2023	11-28	CI
Malaysian Genomics to Deploy AntChain Blockchain Technology	11-09	MT
Malaysian Genomics Unit, Dynamic Prestige Consultancy to Operate Dialysis Centers	11-09	MT
Rinani Genotec Sdn. Bhd. announced that it expects to receive MYR 2.500005 million in funding from Malaysian Genomics Resource Centre Berhad	11-07	CI
Malaysian Genomics Resource Centre Changes Financial Year End to December 31	23-10-26	MT
Malaysian Genomics Resource Centre Berhad Announces Change in Financial Year End from 30 June to 31 December	23-10-25	CI
Malaysian Genomics Resource Centre Berhad Appoints Encik Muhammad Badri Bin Hussin, Age 50, as Member of Audit Committee, Date of Change 25 Oct 2023	23-10-25	CI
Malaysian Genomics Resource Centre Berhad Announces Appointment of Encik Muhammad Badri Bin Hussin as Independent and Non Executive Director	23-10-20	CI

Chart Malaysian Genomics Resource Centre

Duration

Period

Chart Malaysian Genomics Resource Centre

More charts

Malaysian Genomics Resource Centre Berhad is a Malaysia-based company, which is engaged in providing personalized and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services, as well as investment holding. Its services include Genome Sequencing Services, Genome Analysis Services, Genetic Screening Services and Cancer Immunotherapy. Its whole genome sequencing (WGS) is carried out to obtain the sequence of the entire genome from any eukaryotic or prokaryotic organism. This includes plant, animal, microbial, and human genomes. It offers both de novo sequencing and resequencing as part of its WGS service. Its Genome analysis includes services, such as bioinformatics, trait analysis, and trio sequencing. Its Genetic screening includes Dtect, which offers a range of test panels designed to screen for genetic markers in an individualâs deoxyribonucleic acid (DNA). Its Cancer Immunotherapy includes chimeric antigen receptor (CAR) T-Cell immunotherapy.

Sector

Healthcare Facilities & Services

Calendar

2024-08-26 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
MALAYSIAN GENOMICS RESOURCE CENTRE	-8.99%	11.88M
SONIC HEALTHCARE LIMITED	-16.93%	8.48B
RADNET, INC.	+79.26%	4.81B
DR. LAL PATHLABS LIMITED	+16.31%	2.99B
SYNLAB AG	-3.15%	2.65B
NEOGENOMICS, INC.	-4.20%	2.02B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-52.37%	1.87B
FLEURY S.A.	-13.53%	1.58B
METROPOLIS HEALTHCARE LIMITED	+21.59%	1.25B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-47.00%	1.06B

Medical & Diagnostic Laboratories